Chester County News and Community Website
HARRISBURG, PA — The U.S. Department of Agriculture is directing more than $2.2 million to two rural Pennsylvania infrastructure projects aimed at expanding healthcare access and emergency preparedness, investments expected …
USDA Directs $2.2 Million to Rural Health, Emergency Projects in PA Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Hepcludex as the first authorized treatment for chronic hepatitis delta virus infection in the United States, giving patients with the …
FDA Clears First Hepatitis Delta Treatment for U.S. Market Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) plans to begin a rolling FDA biologics license application submission next month for its experimental Friedreich’s ataxia treatment nomlabofusp as the …
Larimar Targets FDA Filing for Friedreich’s Ataxia Drug Read More
PHILADELPHIA, PA — Lannett Company announced that the U.S. Food and Drug Administration approved LANGLARA, an interchangeable biosimilar to Lantus insulin, expanding the number of lower-cost insulin treatment options available …
FDA Approves Interchangeable Lantus Biosimilar for Diabetes Read More
WASHINGTON, D.C. — The United States Department of Transportation will invest more than $750 million to replace eight aging air traffic control towers and radar facilities as part of a …
Transportation Department Funds Air Traffic Tower Upgrades Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently launched new safety reviews of two widely used food additives while finalizing a broader framework for reassessing chemicals already approved …
FDA Expands Review of Food Additives Under Safety Program Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) received U.S. Food and Drug Administration acceptance for its application seeking approval of lorundrostat for uncontrolled or resistant hypertension, moving the company …
Mineralys Advances Hypertension Drug Toward FDA Decision Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) recently received U.S. Food and Drug Administration approval for Jakafi XR, a once-daily extended-release version of ruxolitinib, giving patients with several chronic blood disorders …
FDA Approves Once-Daily Jakafi XR for Blood Disorders Read More
WILMINGTON, DE — An advisory committee to the U.S. Food and Drug Administration voted 7-1, with one abstention, that AstraZeneca’s TRUQAP combination therapy demonstrated a favorable benefit-risk profile for patients …
FDA Panel Backs AstraZeneca Prostate Cancer Drug Combo Read More
WASHINGTON, D.C. — The U.S. Department of Veterans Affairs National Cemetery Administration is partnering with several nonprofit organizations throughout May to host volunteer events and memorial activities honoring veterans buried …
VA, Nonprofits Organize Memorial Day Cemetery Events Read More